Dublin, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The "Endocrine Test Market Value forecast, New Business Opportunities and Companies: Outlook by Type, Application, by End User and by Country, 2020-2026" ...
Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced newly published data in JAMA Network Open showing that Breast Cancer Index® (BCI®) test results led physicians to change their ...
A genomic test led physicians to change extended endocrine therapy recommendations for 42% of people with early-stage HR-positive breast cancer. Results from the Breast Cancer Index (BCI) test led ...
Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced new data demonstrating how the Breast Cancer Index® (BCI™) Test results influence extended endocrine therapy decisions for ...
Hologic’s HOLX acquisition of Biotheranostics in 2021 accelerated its entry into a large, fast-growing oncology adjacency. The business also carries higher margins than the company’s legacy service ...
Hologic, Inc. and its subsidiary, Biotheranostics, Inc., announced newly published data in JAMA Network Open showing that Breast Cancer Index® (BCI®) test results led physicians to change their ...
GLASGOW, Scotland – A machine-learning model can use the results of a simple urine test that measures steroid hormones to assess the likelihood of a person’s hypertension being linked to excess ...
The endocrine system contains eight major glands that make hormones, which travel through the bloodstream to tissues and organs and affect virtually every bodily process. Growth, metabolism, sexual ...
Please provide your email address to receive an email when new articles are posted on . An assessment of free cortisol after a dexamethasone suppression test could add value to the diagnostic workup ...